Efficacy and limitations of a specific immunotherapy in chronic hepatitis B

This publication has 18 references indexed in Scilit:

• Multiepitope Vaccines Intensively Increased Levels of Antibodies Recognizing Three Neutralizing Epitopes on Human Immunodeficiency Virus-1 Envelope Protein
  Scandinavian Journal of Immunology, 2000
• A One-Year Trial of Lamivudine for Chronic Hepatitis B
  New England Journal of Medicine, 1998
• Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.
  Gastroenterology, 1997
• Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children
  New England Journal of Medicine, 1997
• A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
  New England Journal of Medicine, 1995
• Vaccine therapy for hepatitis B virus (HBV)-carriers: A study in murine HBV-carriers on dose, duration & prognosis Third Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan
  Hepatology, 1995
• Vaccines Get a New Twist
  Science, 1994
• Clinical aspects of hepatitis B virus infection
  The Lancet, 1993
• Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
  Annals of Internal Medicine, 1993
• Induction of anti‐hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: A possible way of circumventing “nonresponse” to HBsAg
  Journal of Medical Virology, 1993